Careful selection of anticoagulants and fluid removal rates during dialysis is crucial to prevent cardiac tamponade in patients with uremic pericarditis.
Hypothesis-generating for nafamostat mesylate in uremic pericarditis dialysis; larger prospective studies needed before wider adoption.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Shinoto et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: